drugset / Trial / NCT02696564

Losartan Effects on Emphysema Progression

NCT02696564

RandomizedParallel-groupTriple-blindTreatment

Summary

A randomized, parallel, placebo controlled trial to evaluate the effect of 100mg/day losartan on the progression of emphysema as measured by quantitative HRCT compared to placebo .

Timeline

Start
2017-05-23
Primary completion
2021-03-31
Completion
2021-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Losartan Other / unclassified 100 mg

Indications